MapLight Therapeutics Inc. (MPLT) Live Share Price, Invest From India

MapLight Therapeutics Inc. Stock Performance

as on June 27, 2026 at 2:15 pm IST

Day's Low
Day's High
$31.36
Day's Price Range
$34.37
$33.28
5.77%
Downside
3.28%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$33.28
100.00%
Downside
-100.00%
Upside

MapLight Therapeutics Inc. share price movements today

Previous Close: $31.96
Open: $31.84
Volume: 610.0K
Day's Low - High: $31.36 - $34.37

MapLight Therapeutics Inc. Historical Returns

1 Month Return: + 8.49 %
3 Month Return: + 66.2 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

MapLight Therapeutics Inc. Stock Fundamentals & Key Indicators

Check MapLight Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.4B

EPS (TTM)

-5.16

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-80.95%

MapLight Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MapLight Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
MapLight Therapeutics Inc.	NA	$1.4B	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$39.3B	67.15%	74.07	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$120.6B	147.08%	28.17	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.4B	12.64%	15.22	29.65%	0.58%

Indian Investors' Interest in MapLight Therapeutics Inc. Stock

Search interest for MapLight Therapeutics Inc. Stock has increased by 232% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 30, 2026 to June 29, 2026

Change:232% versus previous 30 day period

MapLight Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2024	Dec 2024	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-
Gross Profit	-	-	0	0	0
Operating Income	-20	-22	-31	-83	-64
EBITDA	-18	-21	-29	-79	-60
Interest Expense	-	-	-	-	-
Depreciation	0	0	0	0	0
Income Before Tax	-19	-21	-29	-79	-60
Income Tax Expense	-	-	-	-	-
Net Income	-19	-21	-29	-79	-60
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

MapLight Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2025
Total Revenue	-
Gross Profit	0
Operating Income	-169
EBITDA	-160
Interest Expense	-
Depreciation	0
Income Before Tax	-161
Income Tax Expense	-
Net Income	-161
Net Profit Margin	0.00%

MapLight Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-18	-18	-19	-21	-22	-29	-29	-79	-60
Operating Cash Flow	-19	-17	-19	-21	-25	-33	-31	-46	-51
Investing Cash Flow	0	-121	8	32	37	17	-135	-242	67
Financing Cash Flow	119	-1	0	0	0	0	198	271	-6
Change in Cash	179	-179	-11	10	50	-16	30	-17	8

MapLight Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Net Income	-55	-77	-161
Operating Cash Flow	-52	-78	-138
Investing Cash Flow	0	-80	-323
Financing Cash Flow	104	118	469
Change in Cash	52	-41	8

Global Institutional Holdings in MapLight Therapeutics Inc.

Funds	Holdings
Pivotal bioVenture Partners Investment Advisor LLC	1.35%
ADAR1 Capital Management LLC	0.83%
BNP Paribas Investment Partners SA	0.59%
FCPM III SERVICES BV	7.12%
Vestal Point Capital LP	0.93%

See all

Insights on MapLight Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, MPLT stock has moved up by 15.5%

About MapLight Therapeutics Inc.

MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company's products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and Alzheimer's disease psychosis; ML-004 for the treatment of social communication deficit and/or irritability in autism spectrum disorder; ML-021 for the treatment of motor deficits in Parkinson's disease; ML-055 for the treatment of neuropsychiatric conditions; and ML-009, a G-protein-coupled receptor 52 positive allosteric modulator for the treatment of hyperactivity, impulsivity and agitation-related disorders. The company also develops platform identifying neural circuits causally linked to disease and targeting those circuits for therapeutic modulation. The company was formerly known as Alvarado Therapeutics, Inc. and changed its name to MapLight Therapeutics, Inc. in August 2019. MapLight Therapeutics, Inc. was incorporated in 2018 and is based in Redwood City, California.

Organisation	MapLight Therapeutics Inc.
Headquarters	800 Chesapeake Drive, Redwood City, CA, United States, 94063
Industry	Biotechnology
CEO	Dr. Christopher A. Kroeger M.B.A., M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of MapLight Therapeutics Inc.

Name	Title
Dr. Christopher A. Kroeger M.B.A., M.D., Ph.D.	Founder, President, CEO & Director
Dr. Robert C. Malenka M.D., Ph.D.	Co-Founder, Member of Scientific Advisory Board & Director

FAQs

What is MapLight Therapeutics Inc. share price today?

MapLight Therapeutics Inc. share price today is $33.28 as on June 27, 2026 at 8:45 am IST at the close of the market. MapLight Therapeutics Inc. share today touched a day high of $34.37 and a low of $31.36.

What is the 52 week high and 52 week low for MapLight Therapeutics Inc. share?

MapLight Therapeutics Inc. share touched a 52 week high of $0 on January 1, 1970 and a 52 week low of $0 on January 1, 1970. MapLight Therapeutics Inc. stock price today i.e. June 27, 2026 at 8:45 am IST is closed at $33.28,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is MapLight Therapeutics Inc.'s market capitalisation today?

MapLight Therapeutics Inc. market capitalisation is $0.00T as on June 27, 2026 at 8:45 am IST.

How to invest in MapLight Therapeutics Inc. Stock (MPLT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for MapLight Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in MapLight Therapeutics Inc. Shares that will get you 0.0451 shares as per MapLight Therapeutics Inc. share price of $33.28 per share as on June 27, 2026 at 8:45 am IST.

What is the minimum amount required to buy MapLight Therapeutics Inc. Stock (MPLT) from India?

Indian investors can start investing in MapLight Therapeutics Inc. (MPLT) shares with as little as ₹94.3 or $1 (as of June 29, 2026 at 3:00 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in MapLight Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 29, 2026 at 3:00 am IST). Based on MapLight Therapeutics Inc. share’s latest price of $33.28 as on June 27, 2026 at 8:45 am IST, you will get 0.3005 shares of MapLight Therapeutics Inc.. Learn more about fractional shares .